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Abstract
Basic epilepsy teachings assert that seizures arise from the cerebral cortex, glossing over infratentorial structures such as the cerebellum that are believed to modulate
rather than generate seizures. Nonetheless, ataxia and other clinical findings in epileptic patients are slowly but inevitably drawing attention to this neural node.
Tracing the evolution of this line of inquiry from the observed coincidence of cerebellar atrophy and cerebellar dysfunction (most apparently manifested as ataxia) in
epilepsy to their close association, this review considers converging clinical, physiological, histological, and neuroimaging evidence that support incorporating the
cerebellum into epilepsy pathology. We examine reports of still controversial cerebellar epilepsy, studies of cerebellar stimulation alleviating paroxysmal epileptic
activity, studies and case reports of cerebellar lesions directly associated with seizures, and conditions in which ataxia is accompanied by epileptic seizures. Finally,
the review substantiates the role of this complex brain structure in epilepsy whether by coincidence, as a consequence of deleterious cortical epileptic activity or
antiepileptic drugs, or the very cause of the disease.
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Introduction
The past 20 years have witnessed a considerable shift in the
understanding of the cerebellum and of its function and involvement
in various conditions. Until quite recently, the cerebellum was thought
to be primarily involved in movement planning and execution.1
Despite reluctant wavering in the literature from the original focus
on motor control, the collective body of research has coalesced around
the astonishing finding that the majority of the human cerebellum
is closely associated with networks involved in cognitive processing
including memory, language, and emotions.1,2 The cerebellum
qmainly communicates with the contralateral cerebrum through two
polysynaptic pathways: the input synapsing at the pons level and the
output channel relaying information from the cerebellar cortex
through the deep cerebellar nuclei to the thalamus and finally various
parts of the cerebral cortex.3,4 The polysynaptic characteristic of this
circuitry has far-reaching implications on possible disturbances arising
from network disruptions, foreshadowing the recently hypothesized
and partly confirmed presence of cerebellar fingerprints in Parkinson’s
disease,5 dystonia,6 schizophrenia,7 essential tremor,8 and other
further syndromes. Significantly less is known about the role of the
cerebellum in epileptogenesis. Cerebellar dysfunction has been
associated with disinhibition of seizure activity in the cerebral
cortex,9–11 and the highly controversial concept of cerebellar epilepsy,
with seizures arising directly from cerebellar structures, has baffled
experts for more than a century.9,12 The cerebellum itself might not be
the initiator, but only another structure experiencing deleterious
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epileptic activity or the long-term effects of some antiepileptic drugs.
Disregarding the ambiguous position of cerebellar atrophy as the
primary cause of seizures, a secondary consequence of epilepsy, or
mere coincidence, it is not necessarily associated with any critical
clinical signature. Even though a significant percentage of patients with
epilepsy (up to 54% in a selected sample of institutionalized patients)
have gait ataxia,13 cerebellar atrophy is not a fundamental prerequisite
for this clinical finding. Hence, our review aims to summarize the
available information on the position of this complex structure in
epilepsy.
Coincidence
Ataxia is a common symptom in a variety of conditions associated
with epilepsy; an overview is provided in Table 1. As mentioned
above, the relationship between epilepsy and cerebellar dysfunction is
complex. The following paragraph and Table 1 provide an overview of
the conditions in which both ataxia and epileptic seizures are observed.
It should be noted that in the majority of such cases there is
presumably a common cause/shared etiology—metabolic, genetic, or
other—concurrently conditioning dysfunction in different regions of
the central nervous system. For example, in type 1 inositol 1,4,5-
trisphosphate receptor deficiency, a mutation of the competent gene
leads to severe ataxia and tonic-clonic seizures due to simultaneous
effects on the hippocampal cornu ammonis 1 region, caudate-
putamen, cerebral cortex, and cerebellar Purkinje cells.14
The combination of ataxia and epileptic seizures has been described in
several channelopathies. For instance, mutation of the voltage-gated
potassium channel gene (KCNJ10) causes EAST syndrome (epilepsy with
partial seizures and generalized seizures, ataxia, tubulopathy, and
sensorineural deafness).15,16 A mutation in the gene encoding the
sodium/hydrogen channel leads to inherited syndromes manifested with
microcephaly, ataxia, disturbances of speech, and epilepsy.15–17 A loss-of-
function mutation of the genes encoding the sodium channels (SCN1A) is
the cause of Dravet syndrome (severe myoclonic epilepsy of infancy,
SMEI).18 Another mutation in a sodium channel-encoding gene (SCNA2)
has been described in connection with neonatal epilepsy, ataxia episodes,
and headaches.19 Similarly, mutations of the voltage-gated calcium channel
subunits were described in absence epilepsy and episodic ataxia.20
Symptomatology comprising cerebellar ataxia and epilepsy can be
also seen in mitochondrial disorders, genetic syndromes, and
myoclonic epilepsies. Ataxia is a part of the symptomatology of
Leigh syndrome,21 Unverricht-Lundborg progressive myoclonic epi-
lepsy,22 Lafora disease,23 and several types of lysosomal storage
disorders.24 Niemann-Pick disease type C is a progressive neurovisceral
metabolic disorder caused by a defect in a recently discovered gene,
NPC-1. The biochemical deficit lies in delayed intracellular cholesterol
transport. Cerebellar Purkinje cell loss is the most significant specific
damage. More recently, significant changes were revealed in
concentrations of neurotransmitters.25 Action myoclonus-renal failure
syndrome is a kind of progressive myoclonic epilepsy with neurological
manifestation of tremor, with later action myoclonus beginning in
young adulthood, and rare generalized epileptic seizures. Cerebellar
symptoms are present, as is ataxia in all cases in the more advanced
stage.26 MERRF (myoclonic epilepsy with ragged-red fibers) is another
rare mitochondrial disorder in this category. Diagnostic criteria
include myoclonus, generalized epilepsy, cerebellar ataxia, and
characteristic muscle biopsy findings (ragged red fibers).27
Progressive ataxia and myoclonic epilepsy were described in a patient
with a homozygous mutation in the FOLR1 gene. Members of this gene
family bind folic acid and its reduced derivatives and transport
5-methyltetrahydrofolate into cells. Dysfunction leads to failure of folate
transportation across the blood-brain barrier. This was described in a
2-year-old child with a morphological defect of myelination failure.28
Epileptic seizures can also be observed in a rare genetic autosomal
recessive ataxia with vitamin E deficiency. A case study described an
affected patient with neurological disabilities from the age of 5 with
epilepsy at 11 years, who was diagnosed at 30 years. At that time, the
neurologic findings were dominated by ataxia, areflexia, dysarthria,
positive pyramidal irritative phenomena, and epilepsy with generalized
seizures. Supplementation with vitamin E suppressed seizures and
stopped neurological deficit progression.29
Glucose transporter-1 deficiency syndrome should be considered in
intractable epilepsy of childhood. It can present with a variety of
symptoms including infantile seizures, developmental delay, movement
disorders, and ataxia. Inadequate glucose transport to neurons results
in impaired cerebral metabolism and disrupted thalamocortical
development. Treatment with a ketogenic diet is well-established and
can result in significant improvement in patient quality of life.30
In gluten enteropathy, epileptic seizures can be observed along with
ataxia, which is quite common.31,32 Selective loss of Purkinje cells has
been described in autoimmune cerebellar ataxia with antigliadin
antibodies; however, in this case, without epilepsy.33
Spinocerebellar ataxia type 10 (SCA10), an autosomal dominant
neurodegenerative disorder, is the result of a noncoding, pentanucleotide
repeat expansion within intron 9 of the ataxin 10 gene. SCA10 patients
present with pure cerebellar ataxia; some families also have a high
incidence of epilepsy.34 The mean age at onset is 35.5 years, and the mean
disease duration is 15.3 years.35 The first sign of disease is usually
unbalanced gait and stance with variable degrees of limb ataxia
characterized by jerky or uncoordinated movements unexplained by motor
weakness or sensory loss. Ataxia is followed by speech difficulties, dysarthria,
and ocular abnormalities. The epilepsy usually presents as generalized
motor seizures and/or complex partial seizures a few years after the start of
cerebellar ataxia. Antiepileptic drugs such as carbamazepine, phenytoin,
and valproic acid are effective for most cases.36
Cerebellar ataxia and epilepsy with antiglutamic acid decarboxylase
(GAD) antibodies is an autoimmune condition. GAD is the enzyme
that catalyzes conversion of glutamate to gamma-aminobutyric acid
(GABA).37 GABA is an inhibitory transmitter of Purkinje cells,38 and
their loss is a well-known result of seizure activity.39 Recent studies
reported that anti-GAD antibodies may be observed in adult-onset
cerebellar syndrome, which is mainly characterized by ataxia, stiffness,
incontinence, retinal pathologies, seizures, and immunological comor-
bidities.40
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Other spinocerebellar ataxias might also be accompanied by
epilepsy, although this is probably a coincidence. There was a case
report of mesiotemporal epilepsy in an SCA13 patient and one of
nocturnal frontal lobe epilepsy in an SCA17 patient.41,42 There was
also a description of epilepsy in patients with Friedreich ataxia.43 A list
of all possible conditions exceeds the scope of this article.
Consequence
In the following paragraphs, we explore a number of possible
explanations for this association, including ataxia as a manifestation of
seizure activity, cerebellar atrophy as a frequent finding in patients
with epilepsy, permanent and transitional morphological changes of
the cerebellum in connection with epilepsy, the possible predictive
value of the extent of cerebellar atrophy for epilepsy surgery outcome,
and ataxia as a negative side effect of antiepileptic medication.
Ataxia may be the result of otherwise silent epileptiform activity in
epileptic patients.44 When it is a form of nonconvulsive seizure activity
in children, it is called pseudoataxia or epileptic ataxia. In some cases,
ataxia might be the first manifestation of an epileptic disorder. When a
child has already been diagnosed and is taking an antiepileptic
medication, then the exclusion of drug levels in the toxic range is an
obvious prerequisite. Suppression of epileptiform discharges is
associated with the disappearance of epileptic ataxia. This condition
is particularly known in pediatric neurology.44
Ataxia can result from cerebellar atrophy, which is a relatively
frequent finding in patients with epilepsy. Cerebellar atrophy is a well-
known occurrence in patients with epilepsy.45 The precision of
evaluation has evolved over time. Older studies determined cerebellar
volume by means of pneumoencephalography46; later diagnostics
included computed tomography and magnetic resonance imaging
scans 47 (Figure 1). The pathogenesis of cerebellar atrophy in patients
with epilepsy nevertheless remains unclear. Is atrophy a primary event
or only the result of epilepsy? To what extent is it caused by
antiepileptic medication?
Some researchers observed significantly smaller cerebellar white
matter volumes in patients with newly diagnosed epilepsy compared to
healthy controls. The researchers assumed that cerebellar white matter
changes meant that the cerebellum is a susceptible structure associated
with the development of partial epilepsy.48 Lawson et al. made a similar
observation in children and assumed that brain volume reduction is
present at epilepsy onset and is not a result of intractable seizures.49
In contrast, some experts have asserted that cerebellar damage does
not appear to be a predisposing factor for epilepsy; rather, it is the
aftermath of epileptic seizures or anticonvulsant medication in patients
with severe and/or long-standing epilepsy.50 Histopathologic changes
including Purkinje cell loss are common in people who experienced
epileptic status, but it has also been detected in patients with only
partial seizures.51 The situation is complex, and the process of
cerebellar damage is influenced by more factors. There is a significant
correlation between cerebellar volume and the total number of
generalized tonic-clonic seizures (GTCSs) and GTCS seizure
frequency.50 Possible seizure-related factors of this phenomenon are
hypoxic-ischemic nerve cell injury during prolonged seizures and
discharges along the cerebrocerebellar connections implicated in the
mechanism of Purkinje cell loss.52
There is also evidence of subtle morphological changes in the
cerebellum and its connections in idiopathic generalized epilepsy.
Li et al. did not observe any cortical abnormalities but demonstrated
a tendency towards a negative correlation between illness duration and
white matter connectivity from the cerebellum to the cortex, along
with cerebellar changes in diffusion tensor imaging.53
Besides the permanent phenomenon of atrophy, transitional
functional changes have been observed, particularly peri-ictal cerebel-
lar hyperperfusion resembling crossed cerebellar diaschisis in supra-
tentorial stroke. Conversely, some authors found no relation between
the site of the single-photon emission computed tomography (SPECT)
seizure localization and the presence or pattern of peri-ictal cerebellar
hyperperfusion (uni- or bilateral).54 Another study reported significant
hypometabolism in the contralateral cerebellum of patients who had
seizure onsets and corresponding hypometabolism in the frontal lobe
and both in the temporal and frontal lobes. In contrast, patients who
had seizure onsets and corresponding hypometabolism mesially in the
temporal lobe tended to have lower values in the ipsilateral
cerebellum.55 In a limited sample from a different study, the authors
noted that crossed cerebellar diaschisis was a frequent finding of ictal
brain SPECT regardless of epileptogenic lesion localization. They
optimistically suggested that such information may aid in lateralizing
epileptic foci.56 A third study that strictly focused on 33 patients with
temporal lobe epilepsy did not demonstrate a significant linkage
between the laterality of cerebral and cerebellar ictal hyperperfusion.57
The functional connection between the cerebellum and hippocampus is
proven. Studies have revealed a dynamic interplay between these
structures during temporal lobe seizures. Hippocampal epileptiform
activity modulates cerebellar activity and vice versa. Excitation or
inhibition of the cerebellum can significantly decrease hippocampal
seizure duration; however, the exact pathways are not yet clear.58
Measuring cerebellar atrophy in patients with epilepsy might be
useful for predicting resective epilepsy surgery outcome. Some reports
have suggested worse outcomes for temporal lobe resection in patients
with intractable epilepsy with cerebellar atrophy.54,59 Our own
observations confirm that the extent of cerebellar atrophy is greater
in a group of patients with persistent seizures than those who are
seizure-free after surgery.
Ataxia might also represent a negative side effect of antiepileptic
medication. Ataxia is especially frequent with the use of phenytoin and
benzodiazepines.60 To varying degrees, ataxia is described as an
adverse side effect of all antiepileptic drugs (Table 2). The issue has
been best studied with phenytoin; high levels are toxic to the cerebellar
cortex and Purkinje cells and may lead to their permanent damage
and/or cerebellar atrophy.61,62 Its long-term administration is
particularly hazardous for ataxia development, and clinical impair-
ment occurs in half of treated patients.63 Ataxia might also be a side
effect of gabapentin, but this drug is also useful in treating ataxia.64 For
instance, in cortical cerebellar atrophy where GABA content reduction
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reflects the loss of Purkinje cells, the GABAergic properties of
gabapentin have a favorable impact.64 Both effects are likely the
result of interference with cerebellar GABAergic neurons, particularly
Purkinje cells, the output neurons of the cerebellar cortex. In valproate
treatment, tremor is more often observed as an adverse event, and
ataxia could be a sign of hyperammonemic encephalopathy.65 Another
reversible form of neurotoxicity was also reported with valproate,
mimicking multiple system atrophy with parkinsonism and cerebellar
symptoms.66
There is very limited information on the exact mechanism by which
most antiepileptic drugs induce ataxia. In addition to affecting the
GABAergic system, analogies dealing with the role of ion channel
dysfunction in ataxias indicate that interactions with ion channels can
also be expected.67
Cause
The relationship between cerebellar damage and seizures has been
known for a surprisingly long time. The role of the cerebellum was
studied in detail as early as in the late 19th century by Hughlings
Jackson.68 He described a particular form of seizure disorder as
‘‘tetanus-like seizures’’ secondary to a tubercular abscess of the middle
lobe of the cerebellum.69 In this case, paroxysmal manifestations are
caused strictly by the cerebellar lesion, and it became apparent that
epileptic seizures arise not only in the cerebral cortex, but also in
subcortical structures and the cerebellum.70,71 Tumorous lesions of the
cerebellum (ganglioglioma,72 ganglioneurocytoma, low-grade astro-
cytoma,73 and hamartoma) and in artificial stimulation of the
cerebellum cause ipsilateral paroxysmal symptoms including facial
grimacing, ipsi- and contralateral head and eye deviation, nystagmus,
and alterations of tone and posture in the ipsi- and contralateral limbs.
In a case report of ganglioglioma of the cerebellar peduncle in
a 4-year-old female with a history of seizures from the age of 2 months,
ictal manifestation was described as follows: clonic twitching of the
ipsilateral hemiface and eyelid often associated with deviation of the
eyes to the side of the lesion, dystonic extension of the ipsilateral arm,
increased respiratory rate, and groaning, followed by short-lasting
apnea. Episodes usually lasted less than 20 s, and consciousness
appeared to be preserved. The seizures occurred almost continuously.
The role of the brainstem nuclei remains unclear, but widespread
brainstem dysfunction seemed unlikely. In all cases, there was normal
scalp electroencephalography (EEG) or only mild and nonspecific
background abnormality. Ictal EEG recordings with implanted depth
electrodes in the cerebellum demonstrated focal seizure discharges in
the region of the tumorous mass.74 Seizures are typically drug resistant
and are possibly cured by lesion resection.72,75–77 In a similar case of
cerebellar ganglioglioma that presented with abnormal movements,
myoclonus was not considered epileptic but was described as
symptomatic. Also in this case, electrophysiological observation
provided evidence that the electrical activity (slow waves) associated
with myoclonus was confined to the cerebellar mass, and tumor
resection led to seizure disappearance.78 Tumorous lesions of the
cerebellum, in the majority of cases mentioned above, contain
neuronal elements, but are not a prerequisite as with cerebellar
astrocytomas.70,73 Astrocytes by themselves participate in epileptogen-
esis, at least in forming the extracellular environment by buffering
potassium cations and maintaining the balance between excitatory and
inhibitory neurotransmitters.79
Cerebellar damage can also indirectly cause epileptic seizures. The
cerebellum has an inhibitory effect on paroxysmal epileptic activity.9,10
Some studies have demonstrated a higher incidence and intensity of
Figure 1. Difficulties in Assessing the Extent of Cerebellar Atrophy. Magnetic resonance imaging in the medial sagittal plane. Left, 40-year-old patient
with temporal lobe epilepsy due to focal cortical dysplasia type II and a 17-year history of predominantly generalized tonic-clonic seizures; right, the average-sized
cerebellum of healthy control. Cerebellar size always should be evaluated with respect to intracranial volume.
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epileptic seizures in patients and animal models with cerebellar
damage.10,11 This is consistent with the hypothesis that the damaged
cerebellum fails to inhibit epileptic seizures. Experimental electrical
stimulation of cerebellar structures can affect epileptic activity within
the cerebral cortex. The effect of such stimulations depends on many
variables such as stimulation frequency and region.9,70 The mechan-
ism of action is supposed to be thalamic inhibition, but the circuits and
influences are less clearly defined.80 The exact mechanism of seizure
activity potentiation in cerebellar lesions is still elusive and remains a
matter of speculation since tangible, direct data are beyond the reach
of current technology. In epileptic patients, the histologic findings of
Purkinje cell loss,51,52 as well as structures exerting inhibitory effects on
the dominantly excitatory cerebellar nuclei, support the hypothesized
disinhibition of their output pathways—the stated cerebellar nuclei
with propagation to the thalamocortical pathway. Furthermore, this
pathology will lead to erroneous performance of the cerebellar
adaptive filter (i.e., the signal patterns leading to unfavorable
outcomes), and epileptic activity will no longer be recognized as such,
so the defective algorithms of the atrophied cerebellar cortex will not
suppress them or ‘‘filter them out.’’ On the other hand, the nature of
epileptic activity inhibition in cerebellar stimulation seems more
complicated. Although crude electric stimulation of the cerebellar
cortex will produce aberrant information flow from the stimulated
cells, their simple hyperactivity will inhibit the excitatory output of
deep cerebellar nuclei and downstream activity in the thalamocortical
pathway. Nonetheless, stimulation of the cerebellar cortex has yielded
inconsistent results.81 In putative contradiction to the above reasoning,
a recent report hypothesized that decreased interictal regional activity
of deep cerebellar nuclei is likely connected with an epileptogenic state.
The expected anticonvulsive effect of deep nuclei stimulation is
explained by its modulation, not simply by excitation or inhibition.82
Buijink et al. reached a similar conclusion when examining brain
atrophy in patients with familial cortical myoclonic tremor with
epilepsy. This heritable disease is characterized by progressive
myoclonus of the distal limbs, infrequent epileptic seizures, signs of
cortical hyperexcitability, and Purkinje cell loss. The authors
concluded that pathologic cerebellar changes, reflected as marked
cerebellar atrophy, can decrease cerebellar inhibition of dentatotha-
Table 2. Antiepileptic Drugs that Induce Cerebellar Ataxia1
1a – Overview of all of the case and cohort studies found in the literature and included in the present review, percentage of affected patients
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lamic-cortical tracts and hypothesized that reduced inhibitory Purkinje
cell output to the dentate nucleus causes this decreased inhibition.83
The 1960s and 1970s were a period of experimentation investigating
the role of the cerebellum in epileptogenesis. In 1972, Hutton
demonstrated the impact of cerebellar lesions on cortical, penicillin-
induced epileptogenic focus in cats. The cerebellum was electrically
stimulated, and several ablations were performed prior to evaluating
the interspike interval of cortical discharges. Stimulation of the vermis
and right paramedian lobes during the early stages of focal seizures
usually resulted in spike inhibition or reduced spike frequency. The
effect of gross surface cerebellar stimulation was similar. Stimulation of
the contralateral dentate nucleus did not produce a regularly
reproducible effect. Stimulation of the contralateral interpositus nuclei
was slightly more effective, while stimulation of the fastigial, ipsilateral
interpositus, and dentate nuclei did not have significant effects on focal
cortical seizures. Ablation of the paramedian lobes and vermis
facilitated seizure activity.11 Recently, cerebellar-directed optogenetic
intervention in a mouse model of temporal lobe epilepsy showed that
excitation of the midline cerebellar Purkinje neurons decreases seizure
frequency. Interventions targeting the cerebellum might therefore offer
a potential therapy for medically intractable epilepsies.84
Our knowledge of the impact of cerebellar stimulation on epileptic
seizures is not limited to animal models. According to a systematic
review by Fontas et al., three clinical double-blind studies used similar
surgical implantation techniques and stimulation targets and para-
meters. Two of them failed to demonstrate any significant seizure
reduction, while the third showed a significant poststimulation
decrease in seizure frequency.80 Cerebellar stimulation can also be
carried out noninvasively by means of transcranial magnetic stimula-
tion (rTMS). In a small sample of six patients with refractory epilepsy,
high-frequency rTMS over the cerebellar cortex was associated with
decreased seizure frequency during treatment of patients with both
single and multiple epileptic foci. However, seizure frequency returned
to baseline levels soon after the end of rTMS.85 The results of
cerebellar stimulation for treating intractable epilepsy are promising
but not yet fully convincing.80
Summary
Some patients with epilepsy display more or less pronounced ataxia
as a manifestation of structural cerebellar impairment. Sometimes this
is a simple coincidence, but in many cases ataxia results from epilepsy
or represents an adverse effect of a specific antiepileptic medication.
Both situations can lead to significant cerebellar atrophy, which is then
reflected in the development of clinical cerebellar symptoms. The
question remains whether such atrophy is the start of a vicious circle in
which a damaged cerebellum loses its inhibitory effect on cerebral
epileptic activity with subsequent worsening of the disease course. The
ability of the cerebellum to indirectly affect epileptic activity within the
cerebral cortex was repeatedly demonstrated in both animal experi-
ments and in clinical epileptology. The direct role of the cerebellum in
human epileptogenesis and the ability of cerebellar structures to
generate epileptic activity appear increasingly realistic given the growing
number of relevant publications. The recognition of the role of the
cerebellum in epileptogenesis has already been put to practical use, and
attempts have been made to control epilepsy by stimulating the
cerebellar cortex and nuclei. The discovery of the most suitable
structures for such interventions should be a subject for further research.
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